Polarized Reflectance Spectroscopy for Oral Lesions

Status Completed

Clinical Trial Summary

In this study the investigators are conducting research to determine whether a new optical device using polarization reflectance spectroscopy can help doctors or dentists identify abnormalities in the mouth that require follow-up. To establish this, measurements are needed from a large number of individuals with different abnormalities in their mouth.

The investigators believe the proposed approach has potential to improve and enable mass screening for precancerous and early cancers of the oral cavity by improving the predictive value of oral cavity exams, particularly for less experienced practitioners.

The information from this study will be compared to results from the pathology report of the tissue taken from your mouth.

Hypothesis:

1. Polarized reflectance spectroscopy can distinguish high-risk oral lesion from normal and reactive oral lesions.

2. Polarized reflectance spectroscopy can capture low-grade oral lesions that have characteristics associated with a high risk of progression to cancer.

Clinical Trial Description

The clinician will place a fiber-optic probe designed to measure the polarized reflectance spectra over the visible optical region on a site of interest in the subject's mouth, including lesional mucosa, normal adjacent and contralateral mucosa. The site for placement of the probe will be determined by the examiner, an experienced Oral Pathologist. The probe examination will take no more than 15 minutes in addition to the subject's appointment time for their routine visits.

A 4um unstained tissue section from surgery or biopsy, part of their scheduled care, will be requested for quantitative histological analysis. The morphometric parameters obtained from polarized reflectance measurements will be compared with the histology and quantitative pathology (nuclear phenotype score) from the tissue sections from the lesion. The collected spectra data from normal looking areas from adjacent normal looking mucosa and contralateral mucosa will be used to determine patient to patient variation in the polarized reflectance of oral mucosa. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01604759
Study type	Interventional
Source	British Columbia Cancer Agency
Contact
Status	Completed
Phase	Phase 1
Start date	December 2011
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Completed	`NCT00158678` - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC	Phase 3
Completed	`NCT00933387` - A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma	Phase 2
Enrolling by invitation	`NCT05030597` - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma	N/A
Completed	`NCT03682562` - Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Recruiting	`NCT03684707` - Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions	Phase 4
Recruiting	`NCT06130332` - Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)	Phase 2
Recruiting	`NCT04372914` - Prevention of Oral DNA Damage by Black Raspberries	N/A
Active, not recruiting	`NCT03529422` - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN	Phase 2
Recruiting	`NCT03686020` - Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
Not yet recruiting	`NCT06060288` - Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Withdrawn	`NCT00951470` - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema	N/A
Completed	`NCT00964977` - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.	Phase 3
Completed	`NCT01418118` - Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery	Phase 4
Active, not recruiting	`NCT00232960` - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC	N/A
Recruiting	`NCT05429099` - Mandibular Reconstruction Preplanning (ViPMR)	Phase 2/Phase 3
Completed	`NCT04614896` - Use of Ultrasound for Measuring Size of Oral Tongue Cancers	N/A
Recruiting	`NCT03685409` - Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions	Phase 3
Completed	`NCT00402779` - Erlotinib Prevention of Oral Cancer (EPOC)	Phase 3
Recruiting	`NCT05153733` - Improved Implant for Reconstruction Purposes After Mandibular Resection	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Polarized Reflectance Spectroscopy for Oral Lesions — PolProbe

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms